| Gene symbol | E7 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_001526.4 (7604..7900) | dbXrefs | |
| Description | transforming protein E7 | ||||
| GTO ID | GTC3518 |
| Trial ID | NCT05952947 |
| Disease | Cervical Cancer | Vulva Carcinoma | Vaginal Carcinoma | Penis Carcinoma | Anal Canal Cancer | Head and Neck Squamous Cell Carcinoma |
| Altered gene | E7 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HRYZ-T101 TCR-T cells |
| HLA | HLA-DRB1*09:01 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Multicenter, Single Arm, Open Label, Phase I Clinical Study to Evaluate the Safety, Tolerability and Efficacy of HRYZ-T101 Injection for HPV18 Positive Solid Tumor |
| Year | 2023 |
| Country | China |
| Company sponsor | SYZ Cell Therapy Co.. |
| Other ID(s) | H-T01-C2001 |
| Cohort 1 | |||||||||
|
|||||||||